The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
19 March 2014
Employment effect (start)
Foreseen end date
31 May 2014
Description
PrimeCell Therapeutics, a global hi-tech company focused in the area of cell therapy and tissue engineering, is to create 100 new jobs with the opening a new 4MEDi biotech park in Ostrava in May 2014. With an investment of CZK 702 million, the biotech park will be one of the largest facilities developing and testing medicines derived from human cells in Europe. It is forecast to grow and should employ up to 250 people in the long-term.
Sources
19 March 2014: Hospodárske noviny
Citation
Eurofound (2014), PrimeCell Therapeutics, Business expansion in Czechia, factsheet number 76732, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76732.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
